Turning Cancer Patients and Caregivers Into Informed Decision- Makers 


Hi, my name is David Emerson, and I have been living with an incurable cancer called Multiple Myeloma since 1994. I started PeopleBeatingCancer.org because I believe that there is a problem with cancer care today.  Cancer patients and caregivers are asked to make huge decisions about their health-- often while woefully uninformed, and under an extreme time crunch. How many of you are here because you were given 24 hours to approve your chemotherapy regimen? 

Let me be clear: knowledge is power. The more you know, the better decisions you'll make for your care.  Yes, I said YOU. You are in control. This website and the non-profit organization that supports it are dedicated to helping cancer survivors and caregivers become informed, educated decision-makers about their treatment. All information found on this site is evidence-based with the studies cited, and actionable-- you can get started using the protocols right away.


Check out our latest blog posts:

Cancer Coaches Help Guide Patients-
Cancer coaches, though, say hospitals sometimes fall short, which is where they come in. “Hospitals often have limited resources, so[...]
Anti-angiogenesis Extends Cervical Cancer Survival
"This study was done to identify a therapeutic option (for cervical cancer) that was tolerable and would lead to improved[...]
Vitamin B Serum Blood Levels as Lung Cancer Therapy
"Conclusion-Serum levels of vitamin B6 and methionine were inversely associated with risk of lung cancer (LC)." If, as the study[...]
Autologous Stem Cell Transplant- NO OVERALL SURVIVAL for Myeloma
These results were confirmed by a meta-analysis that showed a significant benefit for HDT/ASCT in terms of EFS but no[...]
Understanding Blood Clots/VTE and Multiple Myeloma
Risk factors associated with increased risk of VTE among patients with Multiple Myeloma were a history of prior VTE, lenalidomide and[...]
Multiple Myeloma- How to Find and Work with the Best MM Specialists
"Patients who were treated for Multiple Myeloma at higher-volume facilities had a lower risk of mortality compared with those who[...]